NovoSeven RT approved to control surgical bleeding

The FDA has approved Novo Nordisk’s NovoSeven RT (recombinant human coagulation factor VIIa), another formulation of NovoSeven, that can be stored at room temperature (up to 81°F) for up to two years. The original NovoSeven formulation could be stored for 3 years at temperatures between 36–46°F.

NovoSeven RT shares the same indications as NovoSeven, which includes the treatment of bleeding and for surgical prophylaxis in Hemophilia A and B with inhibitors to Factors VIII and IX, in acquired hemophilia, and in congenital FVII deficiency.

For more information call (877) 668-6777 or visit